BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29454384)

  • 41. Human rights and ethics in genomic research: rethinking the model.
    Ashcroft RE
    Pharmacogenomics; 2007 Apr; 8(4):391-5. PubMed ID: 17391075
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ethical, legal, and social issues related to genomics and cancer research: the impending crisis.
    Ellerin BE; Schneider RJ; Stern A; Toniolo PG; Formenti SC
    J Am Coll Radiol; 2005 Nov; 2(11):919-26. PubMed ID: 17411966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. How Much Control Do Children and Adolescents Have over Genomic Testing, Parental Access to Their Results, and Parental Communication of Those Results to Others?
    Clayton EW
    J Law Med Ethics; 2015; 43(3):538-44. PubMed ID: 26479563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Are Data Sharing and Privacy Protection Mutually Exclusive?
    Joly Y; Dyke SOM; Knoppers BM; Pastinen T
    Cell; 2016 Nov; 167(5):1150-1154. PubMed ID: 27863233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Citizens' conceptions of the genome: Related values and practical implications in a citizen forum on the use of genomic information.
    Mayeur C; van Hoof W
    Health Expect; 2021 Apr; 24(2):468-477. PubMed ID: 33453142
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genetic gatekeepers: regulating direct-to-consumer genomic services in an era of participatory medicine.
    Palmer JE
    Food Drug Law J; 2012; 67(4):475-524, iii. PubMed ID: 24640618
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Germline genome-editing research and its socioethical implications.
    Ishii T
    Trends Mol Med; 2015 Aug; 21(8):473-81. PubMed ID: 26078206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
    Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H;
    Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
    Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
    Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participatory Genomic Testing as an Educational Experience.
    Garber KB; Hyland KM; Dasgupta S
    Trends Genet; 2016 Jun; 32(6):317-320. PubMed ID: 27117243
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Growing use of genomic data reveals need to improve consent and privacy standards.
    Kuehn BM
    JAMA; 2013 May; 309(20):2083-4. PubMed ID: 23695456
    [No Abstract]   [Full Text] [Related]  

  • 52. Direct-to-consumer genomic testing: systematic review of the literature on user perspectives.
    Goldsmith L; Jackson L; O'Connor A; Skirton H
    Eur J Hum Genet; 2012 Aug; 20(8):811-6. PubMed ID: 22333900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Direct-to-consumer personal genome testing and cancer risk prediction.
    Bellcross CA; Page PZ; Meaney-Delman D
    Cancer J; 2012; 18(4):293-302. PubMed ID: 22846729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The $1000 genome: ethical and legal issues in whole genome sequencing of individuals.
    Robertson JA
    Am J Bioeth; 2003; 3(3):W-IF1. PubMed ID: 14735880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Healthcare System-Funded Preventive Genomic Screening: Challenges for Australia and Other Single-Payer Systems.
    Lacaze P; Tiller J; Winship I
    Public Health Genomics; 2019; 22(3-4):140-144. PubMed ID: 31550728
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Statement on bioinformatics and capturing the benefits of genome sequencing for society.
    Capps B; Chadwick R; Joly Y; Lysaght T; Mills C; Mulvihill JJ; Zwart H
    Hum Genomics; 2019 May; 13(1):24. PubMed ID: 31142362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research ethics and the challenge of whole-genome sequencing.
    McGuire AL; Caulfield T; Cho MK
    Nat Rev Genet; 2008 Feb; 9(2):152-6. PubMed ID: 18087293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Key Implications of Data Sharing in Pediatric Genomics.
    Rahimzadeh V; Schickhardt C; Knoppers BM; Sénécal K; Vears DF; Fernandez CV; Pfister S; Plon S; Terry S; Williams J; Williams MS; Cornel M; Friedman JM
    JAMA Pediatr; 2018 May; 172(5):476-481. PubMed ID: 29554172
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engagement and communication among participants in the ClinSeq Genomic Sequencing Study.
    Hooker GW; Umstead KL; Lewis KL; Koehly LK; Biesecker LG; Biesecker BB
    Genet Med; 2017 Jan; 19(1):98-103. PubMed ID: 27763633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Opportunities and Challenges in Interpreting and Sharing Personal Genomes.
    Rubin IR; Glusman G
    Genes (Basel); 2019 Aug; 10(9):. PubMed ID: 31450660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.